Medical News

RSS

Personal gender identity of every human being is reflected in the structure of brain networks

Our sense of belonging to the male or female gender is an inherent component of the human identity perception. As a general rule, gender identity and physical sex coincide. If this is not the case, one refers to trans-identity or transsexuality. In a current study, brain researcher Georg S. Kanz of the University Clinic for Psychiatry and Psychotherapy of the MedUni Vienna was able to demonstrate that the very personal gender identity of every human being is reflected and verifiable in the cross-links between brain regions.

9 Jan 2015

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

Nuo Therapeutics, Inc., a pioneer in biodynamic therapies, today announced that it has signed an exclusive licensing and distribution agreement for the Aurix System with Rohto Pharmaceutical Co., Ltd., one of Japan’s leading pharmaceutical, health and wellness companies.

9 Jan 2015

Orlando Regional Medical Center opens new patient tower

As the new year begins, Orlando Health turns the page to a new chapter in patient, guest and team member experience, when Orlando Regional Medical Center opens its new patient tower.

9 Jan 2015

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.

9 Jan 2015

Yeast-eating gut bacteria can help battle bowel problems and autoimmune diseases

Human gut bacteria that feast on the yeast contained in fermented foods like bread and beer provides clues to new treatments for people suffering from bowel diseases.

9 Jan 2015

Sustained quality improvement changes in ICU benefits both patients and health care facility

In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement changes made in an intensive care unit (ICU) were still in practice five years later — benefiting both patients and the health care facility. Those changes included new protocols for treating critically ill patients by encouraging early physical therapy in the ICU.

9 Jan 2015

Tribology and testing of orthopaedic implants white paper published by Lucideon

Lucideon, the international materials development and testing company, has published a new white paper, ‘Tribology and Testing of Orthopaedic Implants’.

From Lucideon 9 Jan 2015

CHLA scientists grow tissue-engineered small intestine from human cells

A new study by researchers at Children's Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.

9 Jan 2015

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.

9 Jan 2015

Some medicines can make skin sun-sensitive, says NPS MedicineWise clinical adviser

Some medicines can make your skin more sensitive to the sun and this summer season NPS MedicineWise advises Australians to check their medicines packaging for warnings to avoid excessive skin exposure to sunlight and sunlamps.

9 Jan 2015

Increased UV radiation can affect human fertility, new NTNU study finds

A new study from the Norwegian University of Science and Technology shows that increased UV radiation can have an effect on human fertility over generations.

9 Jan 2015

Two new ODYSSEY trials meet primary efficacy endpoints

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that two new ODYSSEY trials, which are the first Phase 3 trials to assess alirocumab administered every four weeks, met their primary efficacy endpoints.

9 Jan 2015

Latest wearable tracking devices alone may not change health behavior, say Penn researchers

New Year's weight loss resolutions are in full swing, but despite all the hype about the latest wearable tracking devices, there's little evidence that this technology alone can change behavior and improve health for those that need it most, according to a new online-first viewpoint piece in JAMA.

9 Jan 2015

Tips to avoid winter slips and falls

Tread lightly and don't get too confident; winter is officially here and sidewalks are slippery. About 1 million people take a tumble every year and, according to the Centers for Disease Control and Prevention, approximately 20,000 people die annually due to fall-related injuries.

9 Jan 2015

Man-made insulin nasal spray may improve memory in adults with Alzheimer's-related dementia

A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer's disease dementia, according to a pilot study led by researchers at Wake Forest Baptist Medical Center.

9 Jan 2015

Researchers to explore physical, psychological effects of ultra-endurance running

In the upcoming Race Across USA, ultra-endurance athletes will run a marathon a day as they cover 3,080 miles from California to Maryland.

8 Jan 2015

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration has approved SAVAYSA (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).

8 Jan 2015

Exposure to nanoparticles can play major role in development of cardiovascular diseases

Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system.

8 Jan 2015

One cup of blueberries per day could help reduce blood pressure, arterial stiffness

Just one cup of blueberries per day could be the key to reducing blood pressure and arterial stiffness, both of which are associated with cardiovascular disease.

8 Jan 2015

Scientists discover potential solution to antibiotic resistance

A newly developed technique for screening microbes has led to the discovery of a powerful new antibiotic that can easily kill severe infections in mice, without causing side effects.

8 Jan 2015

Medical News

Personal gender identity of every human being is reflected in the structure of brain networks

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

Orlando Regional Medical Center opens new patient tower

DiaCarta raises $8 million in Series A financing from BVCF

Yeast-eating gut bacteria can help battle bowel problems and autoimmune diseases

Sustained quality improvement changes in ICU benefits both patients and health care facility

Tribology and testing of orthopaedic implants white paper published by Lucideon

CHLA scientists grow tissue-engineered small intestine from human cells

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Some medicines can make skin sun-sensitive, says NPS MedicineWise clinical adviser

Increased UV radiation can affect human fertility, new NTNU study finds

Two new ODYSSEY trials meet primary efficacy endpoints

Latest wearable tracking devices alone may not change health behavior, say Penn researchers

Tips to avoid winter slips and falls

Man-made insulin nasal spray may improve memory in adults with Alzheimer's-related dementia

Researchers to explore physical, psychological effects of ultra-endurance running

Daiichi Sankyo receives FDA approval for SAVAYSA (edoxaban) Tablets

Exposure to nanoparticles can play major role in development of cardiovascular diseases

One cup of blueberries per day could help reduce blood pressure, arterial stiffness

Scientists discover potential solution to antibiotic resistance

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News